Anti-Oxidative Therapy in Diabetic Nephropathy

Area of Science:

• Nephrology
• Diabetology
• Oxidative Stress Research

Background:

• Chronic kidney disease (CKD) is progressive with no cure.
• Diabetic nephropathy is a leading cause of end-stage kidney failure.
• Oxidative stress significantly contributes to kidney damage in diabetic nephropathy.

Purpose of the Study:

• To review oxidative stress in diabetic nephropathy.
• To discuss current treatments and their limitations.
• To explore the potential of antioxidative therapies, focusing on the Nrf2 pathway.

Main Methods:

• Literature review of oxidative stress mechanisms.
• Analysis of current therapeutic strategies for diabetic nephropathy.
• Examination of the role of the Nrf2 pathway in antioxidative defense.

Main Results:

• Hyperglycemia increases reactive oxygen species (ROS) production, exacerbating oxidative stress.
• Existing treatments for diabetic nephropathy have limitations in reversing kidney function decline.
• The Nrf2 pathway presents a potential therapeutic target for managing oxidative stress.

Conclusions:

• Oxidative stress is a key factor in diabetic nephropathy progression.
• Targeting antioxidative defense mechanisms, especially the Nrf2 pathway, offers a promising therapeutic avenue.
• Further research into Nrf2-activating therapies could lead to novel treatments for CKD.